Segmentation by type differentiates the market into three principal product classes, each influencing the overall size in distinct ways. Pure cyclooctatetraene—the undistilled, high‑purity form—captures the largest portion, approximately 55 %, because it meets the stringent specifications of pharmaceutical and high‑performance polymer manufacturers. Stabilized cyclooctatetraene, typically formulated with inhibitors to prevent polymerization, holds a 30 % share, serving customers in organic synthesis where longer shelf‑life and handling safety are paramount. The smallest yet strategically important segment is derivative cyclooctatetraene (e.g., functionalized analogues), contributing about 15 % of revenue; these derivatives enable tailored reactivity for niche applications such as specialty catalysts and advanced material research. This type‑based market taxonomy clarifies how product differentiation drives pricing, supply chain complexity, and ultimately the total market valuation.